I am a neuroscientist and psychiatry resident at Washington University School of Medicine in St. Louis.

I completed my PhD in systems neuroscience in the lab of Maurizio Corbetta, studying the effects of stroke on brain networks. Since then, my professional interest has shifting to developing and understanding novel fast-acting psychopharmacological agents to treat psychiatric illness. I am currently involved in neuroimaging studies of ketamine, psilocybin, allopregnanolone and similar molecules. This is the convergence of my interests in systems neuroscience, neurotransmitters, synaptic plasticity, psychiatry and consciousness.

I am fascinated by all levels of systems neuroscience. The only thing that excites me as much as being a part of the accelerating field of neuroscience is the prospect of using these advances to improve lives. I envision continuing to study neurotransmitter systems and novel psychopharmacology using tools that enable me to interrogate brain-wide circuit level effects.